Published in
Elsevier, Biology of Blood and Marrow Transplantation, 8(24), p. 1602-1609, 2018
DOI: 10.1016/j.bbmt.2018.02.020
Links
Tools
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Journal article published in 2018 by
Yago Nieto 
,
Peter F. Thall,
Junsheng Ma,
Benigno C. Valdez,
Sairah Ahmed ,
Paolo Anderlini,
Uday Popat,
Roy B. Jones,
Elizabeth J. Shpall,
Chitra Hosing,
Muzaffar Qazilbash,
Partow Kebriaei,
Amin Alousi,
Melissa Timmons,
Alison Gulbis
and other authors.
,
Peter F. Thall,
Junsheng Ma,
Benigno C. Valdez,
Sairah Ahmed ,
Paolo Anderlini,
Uday Popat,
Roy B. Jones,
Elizabeth J. Shpall,
Chitra Hosing,
Muzaffar Qazilbash,
Partow Kebriaei,
Amin Alousi,
Melissa Timmons,
Alison Gulbis
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 